feed,title,long_url,short_url
Investors,AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales,https://www.investors.com/news/technology/abbvie-stock-humira-biosimilars-first-quarter-2024/,https://da.gd/XJpe
Investors,"Amazon Earnings Preview: Investors Watching AWS Growth, Ad Push, AI Spending",https://www.investors.com/news/technology/amazon-stock-amzn-q1-earnings-preview-2024/,https://da.gd/PAmS1
